Netherlands Organisation for Scientific Research   Report issue

Government Phase 3 Phase 4
Founded: The Hague Netherlands (1950)

Organization Overview

First Clinical Trial
2000
NCT00158847
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Netherlands Organisation for Scientific Research

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Brain Ischemia (Phase 3)

Candidiasis (Phase 4)

Cerebral Infarction (Phase 3)

Communicable Diseases (Phase 4)

Embolism (Phase 4)

Hemorrhage (Phase 3)

Hypertension (Phase 3)

Infections (Phase 4)

Ischemia (Phase 3)

Lung Diseases, Obstructive (Phase 4)

Pulmonary Disease, Chronic Obstructive (Phase 4)

Pulmonary Embolism (Phase 4)

Respiratory Tract Infections (Phase 4)

Subarachnoid Hemorrhage (Phase 3)

Thrombosis (Phase 4)

Venous Thrombosis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 12